Found 2 clinical trials
A Phase 3, Double-blind, Randomized Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK Inhibitor Therapy and Who Require Red Blood Cell Transfusions (INDEPENDENCE)
The purpose of this Phase 3 study is to evaluate the efficacy and safety of Luspatercept compared with placebo in subjects with myeloproliferative neoplasm (MPN)-associated Myelofibrosis (MF) and anemia on concomitant Janus kinase 2 (JAK2) inhibitor therapy and who require red blood cell count (RBC) transfusions. The study is divided …
cancer
vasectomy
anemia
bilateral oophorectomy
- 36 views
- 28 Oct, 2022
- 163 locations
Establishment of Clinical Basis for Hematopoietic Growth Factors Therapy in Brain Injury
background about neurotrophic and neuroprotective effects of this hematopoietic growth factors therapy.
- 0 views
- 26 Jan, 2021